阿霉素海藻酸钠微球联合碘化油肝动脉栓塞治疗肝癌合并动静脉分流效果观察

doi:10.3969/j.issn.1672-5069.2017.02.035

Abstract

Xue Xingcun，Wu Xuewei.. Efficacy of doxorubicin alginate microspheres combined with lipiodol in transcatheter arterial chemoembolization in treatment of patients with hepatocellular carcinoma and arteriovenous shunt[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 246-247.

References

[1] 王卫东，倪嘉延，许林锋. 对比微球与传统碘油栓塞治疗原发性肝癌疗效. 中华介入放射学电子杂志，2014，2（3）:57-60.
[2] 沈天皓，杨金祖. 肝癌介入治疗栓塞剂研究进展. 黑龙江医学，2014，38（3）:316-319.
[3] Kim DH，Chen J，Reed A，et al. MRI visible drug eluting magnetic microspheres for transcatheter intra-arterial delivery to liver tumors. Larson Theranost，2015，5（5）:477-488.
[4] van Elk M，Ozbakir B，Angelique D，et al. Alginate microspheres containing temperature sensitive liposomes（TSL） for MR-guided embolization and triggered release of doxorubicin. PLoS One，2015，10（11）:141-146.
[5] Xu QX，Xia YJ，Wang CH，et al. Monodisperse double-walled microspheres loaded with chitosan-p53 nanoparticles and doxorubicin for combined gene therapy and chemotherapy. J Control Release，2012，163（2）:130-135.
[6] 雷振武.海藻酸钠微球加固栓塞用于肝癌介入治疗对患者预后情况及血清学指标的影响.中国现代医学杂志，2015，25（28）:41-44.
[7] 宋玉芳，赵京芳，宋玉平. 海藻酸钠微球联合碘化油在TACE中的应用. 中华肿瘤防治杂志，2013，20（15）:1186-1189.
[8] Xu QX，Leong JY，Chua QY，et al. Combined modality doxorubicin-based chemotherapy and chitosan-mediated p53 gene therapy using double-walled microspheres for treatment of human hepatocellular carcinoma. Biomaterials，2013，34（21）: 5149-5162.
[9] 欧盛秋，蒙志斌，范立维，等. 海藻酸钠微球在原发性肝癌肝动脉化疗栓塞治疗中的应用. 山东医药，2013，53（24）:55-56.
[10]张志国，卢桂龙，宋春青.海藻酸钠微球在中晚期原发性肝癌TACE治疗中的应用.西南国防医药，2015，25（10）:1089-1092.
[11] Kim DH， Choy T，Huang S，et al. Microfluidic fabrication of MEAN-eluting magnetic microspheres. Acta Biomater，2014，10（2）:742-750.
[12] 刘卉，陈东风. 血管介入治疗肝癌栓塞材料临床进展. 实用肝脏病杂志，2015，18（3）:333-336.
[13] 刘亚斌，梁明，吕国军. 应用海藻酸钠微球栓塞治疗肝动脉破裂的实验研究. 医学研究生学报，2013，26（3）:248-250.
[14] 王斌，付守忠. 海藻酸钠微球血管栓塞剂治疗原发性肝癌.南通大学学报（医学版），2012，31（1）:83-84.
[15] 王躬莉，陈利荣，王敬. 海藻酸钠微球血管栓塞治疗肝癌的围手术期护理.天津护理，2012，20（3）:149-150.

Efficacy of doxorubicin alginate microspheres combined with lipiodol in transcatheter arterial chemoembolization in treatment of patients with hepatocellular carcinoma and arteriovenous shunt

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Liu Xing, Zhao Shuli, Zhang Dianlong. Effect of sevoflurane inhalation on hepatic ischemia-reperfusion injury in patients with primary liver cancer undergoing partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(5): 728-731.
[2]	Pei Ying, Huang Feng, Yin Hongzhen, et al. Preliminary study on intestinal microecology in mice with xenograft hepatoma intervened by sodiumnorcantharidate [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 486-489.
[3]	Dai Qingyun, Wang Rundong, Jia Weidong. Prediction of early tumor recurrence by predictive nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 561-564.
[4]	Cui Faqiang, Li Tao, Wang Zheng, et al. A pilot study on cetuximab and KRAS gene mutation in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 565-568.
[5]	Yang Fucun, Shang Huaixue, Gai Yonghao. Enhanced magnetic resonance imaging by gadolinium disodium sebacate in diagnosis of patients with focal liver lesions [J]. Journal of Practical Hepatology, 2019, 22(4): 577-580.
[6]	Peng Xinjian, Xiao Yuhui, Xu Siding. Diagnostic value of diffusion-weighted magnetic resonance imaging in patients with radiation-induced liver injury with underlying hepatocelullar carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 373-376.
[7]	Zhao Xiaoguang, Shi Yujie. Protective effect of reduced glutathione on liver function in patients with advanced primary liver cancer underwent transarterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 425-428.
[8]	Li Ketian, Shen Mingge, Wang Fengrong, Hu Chunrong, Cao Yujie, Lu Peng. Impact of blood glucose levels on imaging quality of PET/CT examination in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 256-259.
[9]	Wang Xiuqing, Ma Yanjun, Zhan Jinli. Efficacy of transcatheter arterial chemoembolization and ultrasound-guided microwave ablation in the treatment of patients with hepatocellular carcinoma at special sites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 260-263.
[10]	Zhang Bangjian, Wei Shoucun, Yang Xiaoyan. Effects of dexmedetomidine combined with propofol anesthesia on perioperative stress response and postoperative recovery quality in patients undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 264-267.
[11]	Zhang Xiaozhou, Shuai Ling, Wang Qingda, Yang Nan. Changes of serum miR-335 levels in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 268-271.
[12]	Xu Dafeng, Zhou Kailun, Li Zhuori, et al.. Preliminary observation of miR-144 liposomes on inhibition of proliferation, migration and invasion of liver cancer cells in vitro and in vivo [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 25-28.
[13]	Li Fang, Zou Guizhou, Gao Yufeng, et al.. Frequency of PD-1 copy number variation in individuals with hepatitis B viral infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 37-40.
[14]	Wang Cuixiao, Gao Jing.. Serum Golgi protein 73, lentil lectin-reactive alpha-fetoprotein-L3,AFP andα-L- fucosidase levels in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 113-116.
[15]	Dai Xiaonan, Lyu Jinyan, Weng Wencai, et al.. Expression of IFITM3 in hepatocellular carcinoma and its correlation with intrahepatic tumor recurence after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 117-120.